Market cap for Sembiosys = 9MRE: Valuation TLN vs.Market cap for Sembiosys = 9M
Market cap for Methylgene = 11M
Market cap for Thallion = 10M
Another stupid analysis from our Dumbo. Comparaison with Bioniche is also dead stupid. Bioniche compound is well into phase III, while Shigamabs will only start phase II by mid-year, and has never been tested for efficacy on human. Also, Bioniche deal included 20 M US upfront payment compare with an enormous 2M US upfront for TLN.